Fundraising Fox

Theresa Heggie

Investor

Biopharmaceutical Executive & Board Member at Invivo Capital Partners

About

Accomplished biotech and pharmaceutical executive who joined Freeline as CEO in 2020, with prior senior roles at Alnylam, Bupa, Shire, Baxter, and Janssen. She serves on the boards of BioCryst and ProQR Therapeutics and holds a BSc from Cornell University.

Colleagues at Invivo Capital Partners